# Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease

> **NCT07629245** · PHASE1,PHASE2 · RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 25 (estimated)

## Conditions studied

- Crohn Disease (CD)

## Interventions

- **DRUG:** injection of thawed SVF

## Key facts

- **NCT ID:** NCT07629245
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2028-06-29
- **Final completion:** 2028-06-29
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07629245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07629245, "Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07629245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*